Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 73.03%-2.54K | -6,777.55%-81.8K | -155,292.96%-308.83K | 56.47%-231.5K | -281.31%-223.5K | 86.67%-9.42K | 100.42%1.23K | 199 | -280.46%-531.86K | -367.74%-58.61K |
| Net income from continuing operations | -233.26%-67.49K | -2,144.63%-163.45K | -7,485.46%-500.96K | 85.23%-273.01K | -60.52%-252.26K | 83.14%-20.25K | 88.23%-7.28K | --6.78K | -77.97%-1.85M | -466.41%-157.15K |
| Remuneration paid in stock | --0 | --55.12K | --214.46K | --0 | --0 | --0 | --0 | --0 | --139.37K | --44.73K |
| Other non cashItems | ---- | ---- | ---- | -96.13%47.81K | ---- | ---- | ---- | ---90 | 54.42%1.24M | ---9.81K |
| Change In working capital | 499.68%64.95K | 211.86%26.53K | -239.29%-22.34K | 89.17%-6.3K | -129.95%-19.05K | -78.08%10.83K | 103.74%8.51K | ---6.58K | -158.87%-58.17K | 318.14%63.62K |
| -Change in receivables | 483.39%58.55K | -190.39%-8.6K | -377.91%-8.72K | 20.63%-18.11K | 53.87%-10.53K | ---15.27K | --9.51K | ---1.82K | ---22.82K | -288.61%-22.82K |
| -Change in prepaid assets | ---- | ---- | ---15K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in payables and accrued expense | -75.47%6.4K | 2,106.58%20.13K | 128.95%1.38K | 133.42%11.81K | -111.37%-8.53K | 166.72%26.1K | 99.21%-1K | ---4.76K | -131.56%-35.35K | 2,306.36%74.96K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 73.03%-2.54K | -6,777.55%-81.8K | -155,292.96%-308.83K | 56.47%-231.5K | -281.31%-223.5K | 86.67%-9.42K | 100.42%1.23K | --199 | -280.46%-531.86K | -367.74%-58.61K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 810 | 0 | |||
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --810 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --810 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 853.43%647.81K | 647.81K | 0 | 0 | 0 | -88.88%67.95K | 0 | |||
| Net common stock issuance | ---- | ---- | ---- | --700K | ---- | ---- | ---- | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --2.06K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | -179.85%-54.25K | ---- | ---- | ---- | ---- | -88.88%67.95K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | 853.43%647.81K | --647.81K | --0 | --0 | --0 | -88.88%67.95K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 254.71%33.78K | 1,292.85%115.58K | 5,140.31%424.41K | -98.28%8.1K | -99.85%102 | -93.07%9.52K | -98.05%8.3K | --8.1K | --471.21K | 148.73%66.71K |
| Current changes in cash | 73.03%-2.54K | -6,777.55%-81.8K | -155,292.96%-308.83K | 189.90%416.31K | 823.92%424.31K | 86.67%-9.42K | 100.42%1.23K | --199 | -198.28%-463.11K | -367.74%-58.61K |
| End cash Position | 30,525.49%31.24K | 254.71%33.78K | 1,292.85%115.58K | 5,140.31%424.41K | 5,140.31%424.41K | -99.85%102 | -93.07%9.52K | --8.3K | -98.28%8.1K | -43.32%8.1K |
| Free cash from | 73.03%-2.54K | -6,777.55%-81.8K | -155,292.96%-308.83K | 56.47%-231.5K | -281.31%-223.5K | 86.67%-9.42K | 100.42%1.23K | --199 | -280.46%-531.86K | -367.74%-58.61K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.